Association between interleukin-8 and severity of dengue shock syndrome in children
Abstract
Background Dengue hemorrhagic fever (DHF) remains a major health problem in tropical countries. The case fatality rate (CFR) can be reduced from 45% to <1%, if dengue shock syndrome (DSS) is treated early and adequately. Early biomarkers for DSS outcomes in children are needed. Interleukin-8 (IL-8) might be one of the molecule, as it plays a role in the pathophysiology of DHF in children.
Objective To assess IL-8 levels in pediatric DHF patients at various stages of illness severity and to determine the correlation between serum IL-8 concentration on admission and DSS outcomes in children.
Methods A prospective cohort study was done in children with DSS who were admitted to the Pediatrics Department of Kandou Hospital, Manado. We measured subjects’ serum IL-8 levels at the time of DSS diagnosis and followed-up subjects until there was improvement or deterioration. An association between IL-8 and DSS outcome was analyzed using univariable logistic regression test. An ROC curve and Chi-square test were used to analyze the prognostic value of serum IL-8 levels. Statistical significance was considered to be a P value of <0.05 (power 80, β=0.20)..
Results Fifty-eight children with DSS were included in this study. Twenty-seven subjects had clinical deterioration (to recurrent shock, prolonged shock or died). There was a significant association between elevated IL-8 levels and clinical deterioration in DSS (OR 116.7; 95%CI 18.0 to 756.0; P=0.0001). The ROC curve revealed an IL-8 cut-off level of 194.9 pg/mL, AUC 0.982, with sensitivity 89.3%, specificity 93.3%, positive predictive value (PPV) 92.6%, negative predictive value (NPV) 90.3%.
Conclusion There is an association between elevated early serum IL-8 level and a DSS deterioration. Further prognostic studies are needed to confirm the predictive ability of serum IL-8 level on DSS deterioration in children.
References
2. WHO. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever. Revised and expanded edition. India: WHO; 2011. p. 1-51.
3. Halstead SB. Dengue fever and dengue hemorrhagic fever. In: Berhrman RE, Kliegman RN, Jenson HB, editors. Nelson textbook of pediatrics. 17th ed. Philadelphia: WB Saunders Company; 2007. p. 1092-4.
4. Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbial. 2000;28:183-8.
5. WHO. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. Geneva: WHO; 1997. p.1-60
6. Tatura SNN, Rampengan NH, Mandei JM, Runtunuwu AL, Mantik MFJ, Rampengan TH. Comparison of blood plasma and gelatin solution in resuscitation of children with dengue shock syndrome. Paediatr Indones. 2009;49:322-9.
7. Lin CF, Chiu SC, Hsiao YL, Wan SW, Lei HY, Shiau AL, et al. Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J Immunol. 2005;174:395-403.
8. Huang YH, Lei HY, Liu HS, Lin YS, Liu CC, Yeh TM. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop. Med Hyg. 2000;63:71-5.
9. Talavera D, Castillo AM, Dominguez MC, Gutierrez AE, Meza I. IL-8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol. 2004;85:1801-13.
10. Juffri M, van Der Meer GM, Hack CE, Haasnoot K, Sutaryo, Veerman AJ, et al. Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation. Infect Immun. 2000;68:702-7.
11. Avirutman P, Malasit P, Seliger S, Bhakdi, Husmann M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol. 1998;161:6338-46.
12. Wong HR, Cvijanovich N, Wheeler DS, Bigham MT, Monaco M, Odoms K, et al. Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med. 2008;178:267-82.
13. Huang NT, Lan NT, Lei HY, Lin YE, Lien LB, Huang KJ, et al. Association between sex, nutritional status, severity of dengue hemorrhagic fever, and immune status in infants with dengue hemorrhagic fever. Am J Trop Med Hyg. 2005;72:370–4.
14. Tantracheewathorn T, Tantracheewathorn S. Risk factors of dengue shock syndrome in children. J Med Assoc Thai. 2007;90:272-7.
15. Saniathi E, Arhana BNP, Suandi IKG, Sidiartha IGL. Obesitas sebagai faktor risiko sindrom syok dengue. Sari Pediatri. 2009;11:238-43.
16. Maron GM, Clara AW, Diddle JW, Pleites EB, Miller L, MacDonald G, et al. Association between nutritional status and severity of dengue infection in in children in El Savador. Am J Trop Med Hyg. 2010;82:324-9.
17. Lei HY, Huang KJ, Lin YS, Yeh TM, Liu HS, Liu CC. Immunopathogenesis of dengue hemorrhagic fever. Am J Infect Dis. 2008;4:1-9.
18. Whitehorn J, Simmons CP. The pathogenesis of dengue. Vaccine. 2011;29:7221-8.
19. Raqhupathy R, Chaturvedi UC, Al-Sayer H, Elbishbishi AE, Agarwal R, Nagar R, et al. Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol. 1998;56:280-5.
20. Bethell DB, Flobbe K, Cao XT, Day NP, Pham TP, Buurman WA, et al. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infect Dis. 1998;177:778-82.
21. Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point ans its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology. 2005; 16: 73-81.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Accepted 2016-07-19
Published 2016-07-19